BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Polak D, Talar M, Wolska N, Wojkowska DW, Karolczak K, Kramkowski K, Bonda TA, Watala C, Przygodzki T. Adenosine Receptor Agonist HE-NECA Enhances Antithrombotic Activities of Cangrelor and Prasugrel in vivo by Decreasing of Fibrinogen Density in Thrombus. Int J Mol Sci 2021;22:3074. [PMID: 33802928 DOI: 10.3390/ijms22063074] [Cited by in Crossref: 1] [Cited by in F6Publishing: 3] [Article Influence: 0.5] [Reference Citation Analysis]
Number Citing Articles
1 Gresele P, Momi S. Novel approaches to antiplatelet therapy. Biochemical Pharmacology 2022;206:115297. [DOI: 10.1016/j.bcp.2022.115297] [Reference Citation Analysis]
2 Wang L, Li Y, Yang X, Yang B, Zhang X, Zhang J, Zhang Q, Cheng X, Wang J, Yu N. Purinergic signaling: a potential therapeutic target for ischemic stroke. Purinergic Signalling 2022. [DOI: 10.1007/s11302-022-09905-y] [Reference Citation Analysis]
3 Rukoyatkina N, Shpakova V, Bogoutdinova A, Kharazova A, Mindukshev I, Gambaryan S. Curcumin by activation of adenosine A2A receptor stimulates protein kinase a and potentiates inhibitory effect of cangrelor on platelets. Biochem Biophys Res Commun 2022;586:20-6. [PMID: 34823218 DOI: 10.1016/j.bbrc.2021.11.006] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]